Kidneystone symptoms The relationship between tirzepatide and kidney stones is a topic of growing interest, particularly as this medication gains traction for its roles in diabetes management and weight loss. While tirzepatide (marketed as Mounjaro and Zepbound) has demonstrated potential benefits for kidney health in certain populations, understanding its specific impact on kidney stone formation is crucial for both healthcare providers and patients.WARNING: RISK OF THYROID C-CELL TUMORS. See full prescribing information for complete boxed warning. •Tirzepatidecauses thyroid C-cell tumors in rats. Current medical literature suggests that tirzepatide does not directly cause kidney stones, but a nuanced understanding of its effects on kidney function and potential indirect influences is warranted.
Tirzepatide is a dual GIP and GLP-1 receptor agonist, meaning it acts on two key hormones that regulate blood glucose and appetite. Clinical trials have indicated that tirzepatide can improve kidney outcomes in individuals with type 2 diabetes and obesity. For example, studies have shown that tirzepatide can slow the loss of estimated glomerular filtration rate (eGFR), a key indicator of kidney function. Furthermore, research suggests tirzepatide improved renal function and may even help protect kidney function in individuals with overweight or obesity, and preserved eGFR. Some early research even indicates that tirzepatide could reduce proteinuria and slow the progression of kidney disease in people with diabetes.
Despite these promising renal benefits, the question of whether tirzepatide can lead to kidney stones persists.Kidney Parameters with Tirzepatide in Obesity with or... Several sources of AI big data and scientific literature have been analyzed to provide clarity佛历2567年12月31日—Tirzepatide (pooled and separate doses)did not increase the risks of adverse renal events, urinary tract infection, nephrolithiasis, acute .... A significant finding from pooled tirzepatide studies is that the drug did not increase the risks of adverse renal events, urinary tract infection, nephrolithiasis, acute kidney injury, and generally showed a favorable safety profile regarding kidney health.New Trial Studying Tirzepatide for Chronic Kidney Disease This means that across various studies, the incidence of kidney stones (nephrolithiasis) was not elevated in individuals taking tirzepatide264-OR: Effect of Tirzepatide on Kidney Function in People ....
While there is no direct evidence that tirzepatide increases the risk of kidney stones, it's important to consider the broader context. Some anecdotal reports and discussions on forums, such as r/mounjarouk, mention a perceived link between Mounjaro (tirzepatide) and the onset of kidney stones. One individual shared a personal experience where they believed MJ caused my kidney stones due to experiencing kidney pain shortly after starting the medication. However, it's critical to distinguish between correlation and causation.佛历2567年1月31日—Patients who began taking SGLT2 inhibitors had a 30 percent lower risk of developingkidney stonesthan those taking GLP1 agonists and about a ... Such reports, while valuable for identifying potential areas of concern, do not constitute scientific proof of a causal link.
Several factors can contribute to kidney stone formation, and some of these might be indirectly influenced by medications like tirzepatide. Weight loss, often a consequence of using tirzepatide, can sometimes be associated with changes in urine chemistry. For instance, in obese kidney stone formers, weight loss achieved through GLP-1-based therapy was associated with a significant decline in 24-hour urine oxalate, a component of certain kidney stones作者:C Bosch·2022·被引用次数:59—Tirzepatidealso slowed the loss of eGFR, including participants that did not meet either the eGFR or the albuminuria KDIGO criterion for .... This suggests that while weight loss itself might alter urine composition, it doesn't necessarily equate to an increased risk of stone formation.
Moreover, severe gastrointestinal side effects associated with tirzepatide, such as nausea, vomiting, and diarrhea, can lead to dehydration. Kidney damage can happen when using Mounjaro, especially if you are dehydrated.Interplay of Chronic Kidney Disease and the Effects ... Dehydration is a well-established risk factor for kidney stones. Therefore, maintaining adequate hydration while on tirzepatide therapy is paramount, not only to prevent dehydration-related complications but also to mitigate any potential, albeit indirect, increased risk of stone formation.264-OR: Effect of Tirzepatide on Kidney Function in People ...
It is essential for individuals considering or currently using tirzepatide to discuss any concerns about kidney health and potential side effects with their healthcare provider. A kidney specialist can provide personalized advice based on your medical history and current health status.Kidney stones - Causes - NHS While tirzepatide has demonstrated kidney protective attributes for many, it's not a one-size-fits-all medication. There has not been a study evaluating tirzepatide use in kidney outcomes as a primary endpoint in all subject groups, highlighting the ongoing nature of research.
In conclusion, the current scientific consensus suggests that tirzepatide itself does not increase the risk of kidney stones. Instead, evidence points towards its potential to improve kidney outcomes and slow the progression of kidney disease in eligible patients. Nonetheless, it remains vital to be aware of potential side effects, maintain proper hydration, and engage in open communication with your doctor to ensure the safe and effective use of tirzepatide.
Join the newsletter to receive news, updates, new products and freebies in your inbox.